a clinical-stage biopharmaceutical company, which focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer
Industry Biotechnology
A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with MDGL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then MDGL could also see price increases.
Ticker / NAME | Correlation To ZNTL | 1D Price Change % | ||
---|---|---|---|---|
ZNTL | 100% | -12.15% | ||
MDGL - ZNTL | 51% Loosely correlated | -4.66% | ||
ORMP - ZNTL | 43% Loosely correlated | -4.50% | ||
NRIX - ZNTL | 40% Loosely correlated | -14.67% | ||
VCYT - ZNTL | 39% Loosely correlated | -2.97% | ||
ALLO - ZNTL | 38% Loosely correlated | -7.72% | ||
More |